COMMUNIQUÉS West-GlobeNewswire

Genmab to Present at the 43rd Annual J.P. Morgan Healthcare Conference
03/01/2025
Media Release COPENHAGEN, Denmark; January 03, 2025 Genmab A/S (Nasdaq: GMAB ) announced today that its CEO, Jan van de Winkel, Ph.D., will present a company update at the 4 3 rd Annual J.P. Morgan Healthcare Conference [...]
VALNEVA Declaration of shares and voting rights: December 31, 2024
03/01/2025
VALNEVA Declaration of shares and voting rights December 31, 2024 __________________________________________________________________________________________ Company name: VALNEVA Registered office: 6 rue Alain Bombard, [...]
VALNEVA Déclaration d’actions et de droits de vote : 31 décembre 2024
03/01/2025
VALNEVA Déclaration d’actions et de droits de vote 31 décembre 2024 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège social : 6 [...]
Psychiatric Times® celebrates 40 years at the forefront of psychiatry
03/01/2025
CRANBURY, N.J., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Psychiatric Times ® has been the voice of psychiatry for 40 years. John L. Schwartz, M.D., introduced this innovative platform in 1985 to foster honest and unbiased [...]
Intuitive Announces Executive Leadership Changes to Support Continued Global Growth
03/01/2025
Three executive vice president promotions strengthen core company strategic leadership SUNNYVALE, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care [...]
Cyclacel Pharmaceuticals Announces Agreement for the Acquisition of Preferred Stock by David Lazar
03/01/2025
David Lazar agrees to invest $3.1 million in Preferred Stock and becomes Interim CEO BERKELEY HEIGHTS, N.J., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or [...]
ICU Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
03/01/2025
SAN CLEMENTE, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present [...]
Energroup Holdings Corp (OTC: ENHD) to Acquire Cocannco Inc.
03/01/2025
Energroup to acquire a revenue-generating company and remove its "shell" status SACRAMENTO, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Energroup Holdings Corp. (OTC: ENHD) today announced plans to acquire Cocannco Inc. [...]
NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST
03/01/2025
Company to Provide Overview of Business Model and Expected Revenue Acceleration in Fiscal Year 2025 EDEN PRAIRIE, Minn., Jan. 03, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (" [...]
Safety Shot Launches Revolutionary On-the-Go Stick Packs, Poised to Disrupt the $2 Billion Wellness Market
03/01/2025
JUPITER, Fla., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (the “Company”) today announced a breakthrough in convenient wellness solutions with the launch of its Sure Shot On-the-Go Powder Stick [...]
Carmell Announces Closing of Previously Announced PIPE Investment from Existing and New Investors to Support Commercial Build-out
03/01/2025
PITTSBURGH, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, “we”, “our”, or “us”), today announced the closing of [...]
Madrigal Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
03/01/2025
CONSHOHOCKEN, Pa., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the Company will present at the 43 rd Annual J.P. Morgan Healthcare Conference on Wednesday, [...]
Inari Medical to Present at the J.P. Morgan Healthcare Conference
03/01/2025
IRVINE, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other vascular [...]
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
03/01/2025
DALLAS, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies [...]
Avadel Pharmaceuticals to Provide a Corporate Update and Preliminary Fourth Quarter and Full Year 2024 Financial Highlights on January 8
03/01/2025
DUBLIN, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call [...]
Agios to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025
03/01/2025
CAMBRIDGE, Mass., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that its [...]
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
03/01/2025
LONDON and PHOENIX, Jan. 03, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced that its Chairman of [...]
Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®
03/01/2025
Adds an additional commercial and strategic rare disease product to Eton’s portfolio Galzin is FDA-approved for the treatment of the ultra-rare metabolic condition of Wilson Disease DEER PARK, Ill., Jan. 03, 2025 (GLOBE [...]
SpringWorks Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
03/01/2025
STAMFORD, Conn., Jan. 03, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced that Saqib Islam [...]

Pages